Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Assura plc (AGR) Ord Shs GBP0.10

Sell:75.10p Buy:75.20p 0 Change: 0.40p (0.53%)
FTSE 250:0.24%
Market closed Prices as at close on 19 October 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 0.40p (0.53%)
Market closed Prices as at close on 19 October 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 0.40p (0.53%)
Market closed Prices as at close on 19 October 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company's property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston. The Company's subsidiaries include Abbey Healthcare Group Ltd, Abbey Healthcare Property Investments Ltd, Assura Aspire Ltd, Assura Aspire UK Ltd, Assura HC UK Ltd, Assura Primary Care Properties Ltd and Assura Trellech Ltd.

Contact details

The Brew House, Greenalls Avenue
United Kingdom
+44 (01925) 420660

Important dates

Future events
There are no future events available.
Past events
Quarterly dividend payment date 14 October 2020 14/10/20
Trading Announcement 07 October 2020 07/10/20
Quarterly ex-dividend date 10 September 2020 10/09/20
Annual report 31 July 2020 31/07/20
Quarterly dividend payment date 15 July 2020 15/07/20
AGM 07 July 2020 07/07/20
Trading Announcement 07 July 2020 07/07/20
Quarterly ex-dividend date 11 June 2020 11/06/20
Annual report 09 June 2020 09/06/20
Final results 21 May 2020 21/05/20
Quarterly dividend payment date 15 April 2020 15/04/20
Trading Announcement 02 April 2020 02/04/20
Quarterly ex-dividend date 12 March 2020 12/03/20
Quarterly dividend payment date 15 January 2020 15/01/20
Trading Announcement 13 January 2020 13/01/20
Quarterly ex-dividend date 12 December 2019 12/12/19
Interim results 12 November 2019 12/11/19

General stock information

Market cap:
£2.00 billion
Shares in issue:
2.66 billion
Real Estate Investment Trusts
London Stock Exchange
Sterling pence
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • Jonathan Murphy
    Chief Executive Officer, Executive Director
  • Jayne Cottam
    Chief Financial Officer, Executive Director
  • Orla Ball
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.